top of page


Genpax named 2023 winners of the IET Excellence and Innovation Award for Health Technology
Genpax, a life science startup focused on transforming healthcare in detecting, tracing, and mitigating the spread of bacterial pathogens, has been announced as a winner by the IET for their 2023 Excellence and Innovation Awards. The Awards celebrate the most pioneering engineering and technology innovations across 16 sectors, from energy and sustainability to manufacturing and healthcare. Chosen by a panel of expert judges, Genpax won the Health Technology award for their re
Nov 30, 20232 min read


Genpax Estimates Significant Cost Savings, Health Benefits From WGS Infection Surveillance
NEW YORK – Bioinformatics company Genpax estimates that healthcare systems can save considerable money while preventing infection outbreaks through microbial whole-genome sequencing. In a study published earlier this month in Microbial Genetics, the London-based company calculated that implementing a WGS surveillance strategy could prevent some 74,000 infections annually in England, saving the National Health Service approximately £480 million ($604.5 million) per year, amoun
Sep 7, 20235 min read


Economic and health impact modelling of a whole genome sequencing-led intervention strategy for bacterial healthcare-associated infections for England and for the USA
Download the full paper below: Abstract Bacterial healthcare-associated infections (HAIs) are a substantial source of global morbidity and mortality. The estimated cost associated with HAIs ranges from $35 to $45 billion in the USA alone. The costs and accessibility of whole genome sequencing (WGS) of bacteria and the lack of sufficiently accurate, high-resolution, scalable and accessible analysis for strain identification are being addressed. Thus, it is timely to determine
Sep 7, 20232 min read


Whole Genome Sequencing Can Transform the Management of Healthcare-Associated Infections
A recent economic modelling paper by Genpax, published in Microbial Genomics, concludes that in England, the National Health Service (NHS) could save close to £0.5bn and prevent 1200 avoidable deaths, and the US health system over $3bn and 4,800 deaths by implementing whole genome sequencing (WGS) as a tool to control bacterial healthcare-associated infections. Healthcare-associated infections (HAIs) are a huge economic burden to global healthcare systems. They currently cos
Aug 24, 20232 min read


Genpax Poster: Reference-free Whole Genome SNP analysis of Pseudomonas aeruginosa
Presented by Arthur Poivet at ASM Microbe in Houston, Texas 2023 Download high-resolution pdf below: Supplementary Information
Jun 6, 20231 min read


Genpax Poster: A novel genome comparison tool for same-patient samples of E. coli ST131
Presented by Rebecca Ji Bengtsson at ASM Microbe in Houston, Texas 2023 Download the high-resolution pdf below: Supplementary Information
Jun 6, 20231 min read


Genpax Poster: Large-scale hospital outbreak analysis of Klebsiella pneumoniae
Presented by Ramiro Morales-Hojas at ASM Microbe in Houston, Texas 2023 Download high-resolution pdf below: Supplementary Information
Jun 6, 20231 min read


Genpax Poster: Putting numbers on the economics of WGS
Presented by John Fox at ASM Microbe in Houston, Texas 2024 Bacterial HAIs are a substantial source of global morbidity and mortality, resulting in increased length of hospital stay and high healthcare costs. At Genpax, we're often asked what the benefit of adopting a WGS led intervention strategy could have on hospitals systems, so we developed at thorough model to work it out. Our findings will be presented at the forthcoming ASM Microbe 23 meeting in Houston in June. If y
May 10, 20231 min read


Genpax Poster: A Novel Multi-Scale Outbreak Detection and Strain Identification Capability for Genome Sequence-Based Infection Control: An MRSA Example
Download high-resolution pdf below: A Novel Multi-Scale Outbreak Detection and Strain Identification Capability for Genome Sequence-Based Infection Control: An MRSA Example. J. C. Littlefair, B. Uttley, D. Frampton, J. F. Peden, N. J. Saunders The exclusion (as well as inclusion) of strains is vital for outbreak investigation and infection prevention and control of healthcare-associated infection, for both health resource management and patient-care. Current genome-sequence b
Jun 28, 20222 min read


Is AMR really a product of misuse and abuse by doctors?
It is repeatedly stated that we face a global challenge of antimicrobial resistance and catastrophic health and economic impacts, and that this is the product of misuse, abuse, and essentially over-use of antibiotics. It is hard to argue, and I would not wish to, that this is at least partly the case, but it is both dangerous and misleading to present this as the whole of the explanation. What we are seeing is an inevitable consequence of many pressures and their inevitable e
Jun 1, 20223 min read


What is the larger threat of hospital-associated infection?
COVID-19 is not the pandemic I was predicting. Year after year, for just over 10 years a new class of about 150 young, smart medical students would come to my lectures on medical bacteriology and infection at Oxford. I would explain what things contribute to virulence (what makes pathogens dangerous); most years I would get them to play an online game in which a pandemic was simulated and from which they would learn some key things, with a prize for the person who could take
Mar 1, 20223 min read
bottom of page
